This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Covidien LP. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Paul J Gallogly: Innovator in High Flow Oxygen Therapy
Introduction
Paul J Gallogly is a notable inventor based in Roscommon, Ireland. He has made significant contributions to the field of medical technology, particularly in oxygen therapy. His innovative approach has led to the development of a unique system that enhances patient care.
Latest Patents
Gallogly holds a patent for a "System and method for high flow oxygen therapy." This invention involves a method of high flow oxygen therapy (HFOT) and carbon dioxide (CO2) monitoring. The system delivers HFOT through a central lumen of a nasal cannula, which is designed to optimize the delivery of oxygen while monitoring the patient's exhaled breath for CO2 levels. The nasal cannula features a proximal end and a distal end positioned within the pharynx region of the patient's airway. The method includes sampling exhaled breath via a sampling lumen, which is fluidly coupled to a CO2 monitor, allowing for precise monitoring of the patient's respiratory status.
Career Highlights
Gallogly's career is marked by his dedication to improving respiratory care through innovative solutions. His work at Covidien LP has positioned him as a key player in the development of advanced medical devices. His patent reflects his commitment to enhancing patient outcomes through technology.
Collaborations
Throughout his career, Gallogly has collaborated with esteemed colleagues, including Ronald Thiessen and Seamus P Maguire. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Paul J Gallogly's contributions to high flow oxygen therapy exemplify the impact of innovation in healthcare. His patent and work at Covidien LP highlight the importance of advancing medical technology for better patient care.